Job title: Senior Director & Head of Complex In Vitro Models
Dr. Jason Ekert is head of the Complex In Vitro Models (CIVM) group at GlaxoSmithKline. He leads an integrated enterprise strategy for R&D applications of complex human-relevant and translatable complex in vitro models (eg Spheroids, Organoids, Microphysiological systems and bioprinting). He’s the vice-chair for the IQ-MPS affiliate. Dr Ekert received his PhD in Medical Science from Adelaide University in Australia. He performed post-doctoral training at the University of California, Davis and Coriell Institute for Medical Research. Before coming to GlaxoSmithKline Dr Ekert worked for 11 years at Janssen BioThereapeutics in early biotherapeutic drug discovery in target discovery, drug validation and mechanism of action studies applying complex cell-based assays across multiple therapeutic areas.
Live Q&A – Ask the Speakers Your Burning Questions 3:05 pm
day: Day One
Developing Translationally Relevant 3D Models for Pre-Clinical Drug Development 2:05 pm
Understanding how 3D systems can be used to better characterize molecules, decrease R&D cycle time and reduce attrition Insight from the latest progress in qualifying disease relevant models using spheroids, organoids and microphysiological systems Outlining the industry challenges to accurately model the native tumor microenvironmentRead more
day: Day One